Alexander Y. Tokman, Director at ENDRA Life Sciences Inc. (NDRA), bought 10,000 shares at $0.17 ($2K) on 2022-11-23, disclosed to the SEC on 2022-11-28.
Recurring purchase ($2k) by Director following this insider's established cadence. Pattern-driven, low signal.
Clearly above the average filing.
| Filing → |
| NDRA | SELL | 2021-01-08 | $9K | — | Filing → |
| MVIS | BUY | 2016-12-14 | $100K | — | Filing → |
| MVIS | BUY | 2015-11-16 | $23K | — | Filing → |